Simulation and Stability Assessment of Anti-EpCAM Immunotoxin for Cancer Therapy

Advanced Pharmaceutical Bulletin - Iran
doi 10.15171/apb.2018.052
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Maad Rayan Publishing Company

Related search

Plant-Derived EpCAM Antigen Induces Protective Anti-Cancer Response

Cancer Immunology, Immunotherapy
Cancer ResearchMedicineOncologyAllergyImmunology
2007English

A Phase I Study of an Intravesically Administered Immunotoxin Targeting EpCAM for the Treatment of Nonmuscle-Invasive Bladder Cancer in BCG-refractory and BCG-intolerant Patients

Drug Design, Development and Therapy
Drug DiscoveryPharmacologyPharmaceutical Science
2010English

Analysis of the Specificity and Selectivity of Anti-EpCAM Antibodies in Breast Cancer Cell Lines

Folia Histochemica et Cytobiologica
MedicineForensic MedicinePathologyHistology
2012English

Repurposed Anti-Cancer Drugs: The Future for Anti-Infective Therapy?

Expert Review of Anti-Infective Therapy
VirologyInfectious DiseasesMicrobiology
2020English

A Novel Anti-Vascular Therapy for Cancer

Cancer Biology and Therapy
Cancer ResearchOncologyMolecular MedicinePharmacology
2004English

Apoptosis in Cancer Pathogenesis and Anti-Cancer Therapy

Advances in Experimental Medicine and Biology
BiochemistryMedicineGeneticsMolecular Biology
2016English

Selective Anti-Gene Therapy for Cancer: Principles and Prospects.

Tohoku Journal of Experimental Medicine
BiochemistryMedicineGeneticsMolecular Biology
1992English

Development of Therapeutic Anti-Jagged1 Antibodies for Cancer Therapy

Molecular Cancer Therapeutics
Cancer ResearchOncology
2019English

Anti‑EpCAM Antibodies for Detection of Metastatic Carcinoma in Effusions and Peritoneal Wash

Oncology Letters
Cancer ResearchOncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy